Brevan Howard Capital Management LP

Position in HIMS — Hims & Hers Health, Inc.

CIK 1512857 ST. HELIER, Y9

Back to HIMS Full portfolio

Position in HIMS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,322,591

+$945,009 QoQ

Shares Held

38,148

+109.7% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#194

of 504 holders

Holding Since

Dec 2023

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in HIMS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Brevan Howard Capital Management LP holds $20,713,489 across 26 Drug Manufacturers - Specialty & Generic names. HIMS ranks #7 (6.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc	231,624	$3,678,189
2	UTHR	UNITED THERAPEUTICS Corp	4,174	$2,261,598
3	ZTS	Zoetis Inc.	26,423	$1,898,755
4	LQDA	Liquidia Corp	20,664	$1,647,540
5	LNTH	Lantheus Holdings, Inc.	14,589	$1,618,503
6	AMRX	Amneal Pharmaceuticals, Inc.	85,545	$1,480,783
7	HIMS	Hims & Hers Health, Inc. This page	38,148	$1,322,591
8	BCRX	Biocryst Pharmaceuticals Inc	96,574	$965,740

All Filings in HIMS

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,322,591	38,148	+109.7%	Shares	Defined	2026-08-14
2026-03-31	$377,582	18,188	-52.2%	Shares	Defined	2026-05-15
2025-12-31	$1,235,321	38,045	+244.9%	Shares	Defined	2026-02-17
2025-09-30	$625,735	11,032	-78.6%	Shares	Defined	2025-11-14
2025-06-30	$2,569,667	51,548	+7.0%	Shares	Defined	2025-08-14
2025-03-31	$1,422,950	48,154	-38.3%	Shares	Defined	2025-05-15
2024-12-31	$1,888,554	78,104	+27.2%	Shares	Defined	2025-02-14
2024-09-30	$1,130,601	61,379	+502.1%	Shares	Defined	2024-11-14
2023-12-31	$90,735	10,195	—	Shares	Defined	2024-02-14
No filing history on record for this holder in this stock.